Anti-Cancer Agents in Medicinal Chemistry
Formerly: Current Medicinal Chemistry - Anti-Cancer Agents
Volume 19, 18 Issues, 2019
ISSN: 1875-5992 (Online)
ISSN: 1871-5206 (Print)
This journal supports open access
ISSN: 1875-5992 (Online)
ISSN: 1871-5206 (Print)
This journal supports open access
Ranking and Category
-
39th of 61 in
Chemistry, Medicinal
-
172nd of 229 in
Oncology
Contents
Anti-Cancer Agents in Medicinal Chemistry, Volume 11 - Number 5
Editorial [Hot Topic: Emerging Therapeutic Targets and Agents for Pancreatic Cancer Therapy (Guest Editor: Dr. Felix Ruckert)]
, 11(5): 408 - 410Susanne Sebens and Holger Kalthoff
DOI: 10.2174/187152011795677418
An Update on Molecular Research of Pancreatic Adenocarcinoma
, 11(5): 411 - 417Christian Krautz, Felix Ruckert, Hans-Detlev Saeger, Christian Pilarsky and Robert Grutzmann
DOI: 10.2174/187152011795677409
Combination Therapy for the Treatment of Pancreatic Cancer
, 11(5): 418 - 426William Greenhalf and Amy Thomas
DOI: 10.2174/187152011795677391
Insulin-Like Growth Factor Signaling as a Therapeutic Target in Pancreatic Cancer
, 11(5): 427 - 433Simon Rieder, Christoph W. Michalski, Helmut Friess and > Kleeff
DOI: 10.2174/187152011795677454
Aptamers: Potential Applications to Pancreatic Cancer Therapy
, 11(5): 434 - 441Kristy L. Rialon and Rebekah R. White
DOI: 10.2174/187152011795677472
Genes Associated with Epithelial-Mesenchymal Transition: Possible Therapeutic Targets in Ductal Pancreatic Adenocarcinoma?
, 11(5): 448 - 454Hubert G. Hotz, Birgit Hotz and Heinz-Johannes Buhr
DOI: 10.2174/187152011795677436
Targeting Phosphoinositide 3-Kinase Pathways in Pancreatic Cancer – from Molecular Signalling to Clinical Trials
, 11(5): 455 - 463Marco Falasca, Federico Selvaggi, Richard Buus, Sara Sulpizio and Charlotte E. Edling
DOI: 10.2174/187152011795677382
Anti-Angiogenic Agents in Pancreatic Cancer: A Review
, 11(5): 464 - 469Murwarid M. Assifi and Oscar J. Hines
DOI: 10.2174/187152011795677463
Pancreatic Cancer in Obesity: Epidemiology, Clinical Observations, and Basic Mechanisms
, 11(5): 470 - 478Nicholas J. Zyromski and Patrick B. White
DOI: 10.2174/187152011795677445
  |
Editor-in-Chief
Michelle Prudhomme
Institut de Chimie de Clermont-Ferrand
ICCF-CNRS UMR 6296
Université Clermont Auvergne
Clermont-Ferrand
France
Biography
View Full Editorial Board
Institut de Chimie de Clermont-Ferrand
ICCF-CNRS UMR 6296
Université Clermont Auvergne
Clermont-Ferrand
France
Biography
Biography of Michelle Prudhomme
Prof. Michelle Prudhomme holds the position of Emeritus Professor at the Blaise Pascal University of Clermont-Ferrand, France. She was awarded Doctor-Engineer degree at the University of Caen France where her research focused on the synthesis of sulfur compounds. Then she received her Ph.D. Degree at the University of Clermont-Ferrand, France, after works on antibiotics. She developed projects related to drug design and discovery of cytotoxic compounds. She has authored or co-authored 108 research and review articles and and 6 patents.
Dr. Michelle Prudhomme was the founding Editor (2000) and is currently the Editor-in-Chief of this journal (Anti-Cancer Agents in Medicinal Chemistry), published by Bentham Science Publishers.
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Medicinal Chemistry - Anti-Cancer Agents was launched in 2001 and later renamed in 2006 as Anti-Cancer Agents in Medicinal Chemistry.
Scopus CiteScore Metrics: 2.01
Highlighted Articles
Differential Effects of Antofine N-Oxide on Solid Tumor and Leukemia Cells, 2014: 14(10); 1315 - 1323
View Abstract Rights and Permissions
Differential Effects of Antofine N-Oxide on Solid Tumor and Leukemia Cells, 2014: 14(10); 1315 - 1323
Tania Bour, Xianwen Yang, Weihong Li, Francois Bernardin, Tony Kaoma, Arnaud Muller, Laurent Vallar and Andre Steinmetz.
View Abstract Rights and Permissions
Advertisement
Webmaster Contact: info@benthamscience.net